Injection/Infusion
ABILIFY ASIMTUFII EXTENDED-RELEASE INJECTABLE SUSPENSION IN PRE-FILLED SYRINGE 720MG/2.4ML
Summary
ABILIFY ASIMTUFII EXTENDED-RELEASE INJECTABLE SUSPENSION IN PRE-FILLED SYRINGE 720MG/2.4ML — Injection/Infusion containing aripiprazole. Hong Kong Registration No. HK-69170. Certificate Holder: OTSUKA PHARMACEUTICAL (H.K.) LIMITED. Date of Registration: 31 Jul, 2026.
Product NameABILIFY ASIMTUFII EXTENDED-RELEASE INJECTABLE SUSPENSION IN PRE-FILLED SYRINGE 720MG/2.4ML
Registration No.HK-69170
Certificate HolderOTSUKA PHARMACEUTICAL (H.K.) LIMITED
Holder AddressRM 1801, 18/F, LEE GARDEN 3, 1 SUNNING ROAD, CAUSEWAY BAY, HONG KONG
Ingredientsaripiprazole
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration31 Jul, 2026
ATC codesN05AX12
ATC Classification
ATC level 1
N Nervous System
All ATC groupsN05
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。